Clinical trials have led to the development of better treatments, life-saving medicines, and new prevention strategies for many cancer types.
Still, historically, clinical trials have low representation among Latinos and other people of color.
We need diverse representation in cancer clinical trials to ensure that health and medical discoveries are equitable for diverse populations.
To promote clinical trials, let’s use #SaludTues on Tuesday, April 5, 2022, to discuss cancer clinical trials, why they are so important, and how we all can step up to increase diversity and equitable cancer research, in honor of National Minority Health Month in April.
- WHAT: #SaludTues Tweetchat: How to Encourage and Achieve Diversity in Cancer Clinical Trials
- TIME/DATE: 1-2 p.m. ET (Noon-1 p.m. CT), Tuesday, April 5, 2022
- WHERE: On Twitter with hashtag #SaludTues
- HOST: @SaludAmerica
- CO-HOSTS: Susan G. Komen (@SusanGKomen); Public Health Maps (@PublicHealthMap)
- HASHTAG: #SaludTues
- OPTIONAL HASHTAG: #NMHM2022
We’ll open the floor to your comments, tips, and stories as we explore:
- What is a clinical trial?
- Why is it so important for Latinos and other people of color to participate in cancer clinical trials?
- What barriers do people of color face when it comes to cancer clinical trials, and how can we remove those barriers?
- How can we encourage diversity and equitable participation in cancer clinical trials?
Be sure to use the hashtag #SaludTues to follow the conversation on Twitter and share your strategies, stories, and resources to explore how clinical trials can make a huge difference in the lives of Latinos!
#SaludTues is a monthly health equity tweetchat focused on health equity and the Latino population at 12p CT/1p ET on the first Tuesday of each month. #SaludTues is hosted by the @SaludAmerica program at the Institute for Health Promotion Research at UT Health San Antonio.
The post #SaludTues Tweetchat 4/5: How to Encourage and Achieve Diversity in Cancer Clinical Trials appeared first on Salud America.Recommend0 recommendationsPublished in